| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/11/1992 | CA1295566C Characterization and structure of genes for protease a and protease b from streptomyces griseus |
| 02/11/1992 | CA1295564C Recombinant plasmid inserted with herpes simplex virus gene |
| 02/11/1992 | CA1295563C Production of active proteins containing cystine residues |
| 02/11/1992 | CA1295562C DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO |
| 02/11/1992 | CA1295561C Production of herpes simplex viral proteins |
| 02/11/1992 | CA1295558C Synthesis of long chain dna |
| 02/10/1992 | WO1992002641A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/10/1992 | WO1992002629A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 02/10/1992 | CA2089088A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/10/1992 | CA2088905A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002621A2 Allergens of alder pollen and applications thereof |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2067144A1 Allergens of alder pollen and applications thereof |
| 02/08/1992 | WO1992002639A1 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal |
| 02/07/1992 | WO1992002549A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2088988A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin |
| 02/06/1992 | WO1992001816A1 Human herpesvirus-7 |
| 02/06/1992 | WO1992001810A1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 02/06/1992 | WO1992001798A1 Srb1 encoding gene and yeasts transformed with this gene |
| 02/06/1992 | WO1992001796A1 Mycobacterial expression vector |
| 02/06/1992 | WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 02/06/1992 | WO1992001789A1 Stable and bioactive modified somatotropins |
| 02/06/1992 | WO1992001788A1 Beta chain of the human gm-csf receptor and uses thereof |
| 02/06/1992 | WO1992001784A1 Rotavirus reassortant vaccine |
| 02/06/1992 | WO1992001783A1 Dna capable of site-specific integration into mycobacteria |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001717A1 Bacterial stress proteins |
| 02/06/1992 | WO1992001716A1 Protease resistant pdgf and methods of use |
| 02/06/1992 | WO1992001714A1 Non-a non-b hepatitis virus antigen |
| 02/06/1992 | WO1992001713A1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 02/06/1992 | WO1992001710A1 Anticoagulant peptides |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001705A1 Plasmodium vivax and plasmodium knowlesi duffy receptor |
| 02/06/1992 | WO1992001703A1 Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/06/1992 | WO1992001462A1 Amphiphilic peptide compositions and analogues thereof |
| 02/06/1992 | WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | WO1992000323A3 Human cytomegalovirus (hcmv) antigen pp150 |
| 02/06/1992 | DE4024187A1 Mutagenesis of plasmids in form of gapped circles - by hybridisation with mutagenic oligo:nucleotide, then selective linearisation of non-mutated circles |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/05/1992 | EP0469985A1 Process for manufacturing von Willebrand factor having a very high purity |
| 02/05/1992 | EP0469359A2 Method and product for the treatment of gastric disease |
| 02/05/1992 | EP0469348A2 cDNA sequence and detection of hepatits C virus |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0469089A1 Generation of hybrid genes and proteins by virus-mediated recombination |
| 02/05/1992 | EP0469036A1 Composition and treatment with biologically active peptides and antibiotic. |
| 02/05/1992 | EP0468998A1 Peptides having novel polar n-terminal groups |
| 02/05/1992 | EP0193585B1 Cross-reactive and protective epitopes of circumsporozoite proteins |
| 02/05/1992 | EP0191772B1 Acid-cleavable compound |
| 02/04/1992 | WO1992005252A1 STABLE PROPAGATION OF MODIFIED FULL LENGTH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN cDNA IN HETEROLOGOUS SYSTEMS |
| 02/04/1992 | WO1992002619A1 Plasmid for use in producing inflamed region derived phospholipase a2 inhibitory protein, microbial cell, and production and use of said protein |
| 02/04/1992 | WO1992002547A1 Method for treating immune system dysfunctions |
| 02/04/1992 | US5086169 Dna sequence for hybridizatin by gene expression |
| 02/04/1992 | US5086165 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
| 02/04/1992 | US5086164 Novel methods and compositions for treatment of angiogenic diseases |
| 02/04/1992 | US5086042 Capable of stimulating contraction of gall bladder; having six to nine amino acids with sulfonated tyrosine and C-terminal amides; treating obesity |
| 02/04/1992 | US5086039 Pharmaceutical compositions and use thereof in treating inflammation |
| 02/04/1992 | US5085984 Novel type VI bacterial Fc receptors |
| 02/04/1992 | US5085862 Mutants, vaccine; immunoprotective in mice |
| 02/04/1992 | CA2088679A1 Method for treating immune system dysfunctions |
| 02/04/1992 | CA2067237A1 Plasmid and microbial cell for production of an inhibitory protein for phospholipase a2 from inflammatory sites, and the production and use of said protein |
| 02/04/1992 | CA1295245C Stable formulation of biologically active proteins for parenteral injection |
| 02/04/1992 | CA1295241C Lymphokine and its production and uses |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002253A1 INTERLEUKIN-4 AND INTERLEUKIN-1β SYNERGISTICALLY INDUCE VCAM-1 |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 01/30/1992 | DE4107765A1 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt Pancreatic elastase-1-specific antibodies, a process for its production and to a test kit which such antibody contains |
| 01/30/1992 | DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies |
| 01/30/1992 | DE4023721A1 Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s) |
| 01/29/1992 | WO1992002630A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 01/29/1992 | EP0468946A1 Enzymatic method of determining beta-lactam ring antibiotics |
| 01/29/1992 | EP0468764A1 Method for administering a therapeutic anticoagulant |
| 01/29/1992 | EP0468714A2 Peptide-polysaccharide-protein conjugate vaccines |
| 01/29/1992 | EP0468657A2 Non-A non B hepatitis-specific antigen and its use in hepatitus diagnosis |
| 01/29/1992 | EP0468637A1 In vivo targeting with bifunctional antibodies |
| 01/29/1992 | EP0468601A1 Methods and materials for HIV detection and therapy |
| 01/29/1992 | EP0468591A2 Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products |
| 01/29/1992 | EP0468590A2 Dicarboxylic acid oxidation products |
| 01/29/1992 | EP0468539A1 Hirudin derivatives |
| 01/29/1992 | EP0468527A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
| 01/29/1992 | EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 01/29/1992 | EP0468448A2 Analogs of hirudin having antiplatelet activity |
| 01/29/1992 | EP0468441A1 Use of particular compounds for manufacture of pharmaceutical formulations for metabolic treatments |
| 01/29/1992 | EP0468393A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
| 01/29/1992 | EP0468337A1 DNA coding for a human vasoconstrictive peptide and use thereof |
| 01/29/1992 | EP0468257A1 Multimeric form of human rhinovirus receptor protein |
| 01/29/1992 | EP0468181A2 Process for the purification of factor VIII and factor VIII obtained by said process |
| 01/29/1992 | EP0467992A1 Process for purifying a protein |
| 01/29/1992 | EP0467991A1 Platelet membrane microparticles |
| 01/29/1992 | EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system |
| 01/29/1992 | EP0467972A1 Rickettsial antigens for vaccination and diagnosis |